Your browser doesn't support javascript.
loading
Inherited p40phox deficiency differs from classic chronic granulomatous disease.
van de Geer, Annemarie; Nieto-Patlán, Alejandro; Kuhns, Douglas B; Tool, Anton Tj; Arias, Andrés A; Bouaziz, Matthieu; de Boer, Martin; Franco, José Luis; Gazendam, Roel P; van Hamme, John L; van Houdt, Michel; van Leeuwen, Karin; Verkuijlen, Paul Jh; van den Berg, Timo K; Alzate, Juan F; Arango-Franco, Carlos A; Batura, Vritika; Bernasconi, Andrea R; Boardman, Barbara; Booth, Claire; Burns, Siobhan O; Cabarcas, Felipe; Bensussan, Nadine Cerf; Charbit-Henrion, Fabienne; Corveleyn, Anniek; Deswarte, Caroline; Azcoiti, María Esnaola; Foell, Dirk; Gallin, John I; Garcés, Carlos; Guedes, Margarida; Hinze, Claas H; Holland, Steven M; Hughes, Stephen M; Ibañez, Patricio; Malech, Harry L; Meyts, Isabelle; Moncada-Velez, Marcela; Moriya, Kunihiko; Neves, Esmeralda; Oleastro, Matias; Perez, Laura; Rattina, Vimel; Oleaga-Quintas, Carmen; Warner, Neil; Muise, Aleixo M; López, Jeanet Serafín; Trindade, Eunice; Vasconcelos, Julia; Vermeire, Séverine.
Afiliación
  • van de Geer A; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Nieto-Patlán A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Kuhns DB; Paris Descartes University, Imagine Institute, Paris, France.
  • Tool AT; Department of Immunology, National School of Biological Science, National Polytechnic Institute, ENCB - IPN, Mexico.
  • Arias AA; Neutrophil Monitoring Laboratory, Clinical Services Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Bouaziz M; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • de Boer M; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, and.
  • Franco JL; School of Microbiology, University of Antioquia, Medellin, Colombia.
  • Gazendam RP; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • van Hamme JL; Paris Descartes University, Imagine Institute, Paris, France.
  • van Houdt M; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • van Leeuwen K; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, and.
  • Verkuijlen PJ; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • van den Berg TK; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Alzate JF; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Arango-Franco CA; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Batura V; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Bernasconi AR; Department of Blood Cell Research, Sanquin Research, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Boardman B; Department of Molecular Cell Biology and Immunology, VU Medical Center, VU University, Amsterdam, Netherlands.
  • Booth C; National Center for Genomic Sequencing - CNSG-SIU, School of Medicine, University of Antioquia, Medellin, Colombia.
  • Burns SO; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, and.
  • Cabarcas F; School of Microbiology, University of Antioquia, Medellin, Colombia.
  • Bensussan NC; Department of Pediatrics and Biochemistry, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Charbit-Henrion F; Service of Immunology and Rheumatology, Garrahan National Pediatric Hospital, Buenos Aires, Argentina.
  • Corveleyn A; Department of Pediatric Allergy and Immunology, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom.
  • Deswarte C; Department of Immunology, Great Ormond Street Hospital, NHS Foundation Trust, London, United Kingdom.
  • Azcoiti ME; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Foell D; Department of Clinical Immunology, Royal Free London, NHS Foundation Trust, London, United Kingdom.
  • Gallin JI; National Center for Genomic Sequencing - CNSG-SIU, School of Medicine, University of Antioquia, Medellin, Colombia.
  • Garcés C; SISTEMIC Group, Electronic Engineering Department, University of Antioquia, Medellin, Colombia.
  • Guedes M; Laboratory of Intestinal Immunity, INSERM U1163, Imagine Institute, Paris, France.
  • Hinze CH; GENIUS group (GENetically ImmUne-mediated enteropathieS) of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
  • Holland SM; Paris Descartes University, Paris, France.
  • Hughes SM; Laboratory of Intestinal Immunity, INSERM U1163, Imagine Institute, Paris, France.
  • Ibañez P; GENIUS group (GENetically ImmUne-mediated enteropathieS) of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
  • Malech HL; Paris Descartes University, Paris, France.
  • Meyts I; Pediatric Gastroenterology, Hepatology and Nutrition Unit, AP-HP, Necker Hospital for Sick Children, Paris, France.
  • Moncada-Velez M; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Moriya K; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Neves E; Paris Descartes University, Imagine Institute, Paris, France.
  • Oleastro M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Perez L; Department of Immunology, Ricardo Gutierrez Children's Hospital, Buenos Aires, Argentina.
  • Rattina V; Department of Pediatric Rheumatology and Immunology, Munster University Hospital, Munster, Germany.
  • Oleaga-Quintas C; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Warner N; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, and.
  • Muise AM; Department of Pediatrics, Santo Antonio Hospital, Porto, Portugal.
  • López JS; Department of Pediatric Rheumatology and Immunology, Munster University Hospital, Munster, Germany.
  • Trindade E; Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
  • Vasconcelos J; Department of Pediatric Allergy and Immunology, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom.
  • Vermeire S; Inflammatory Bowel Disease Program, Gastroenterology Department, Clinic Las Condes Medical Center, University of Chile, Santiago de Chile, Chile.
J Clin Invest ; 128(9): 3957-3975, 2018 08 31.
Article en En | MEDLINE | ID: mdl-29969437
Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries. These patients display 8 different in-frame or out-of-frame mutations of NCF4 that are homozygous in 11 of the families and compound heterozygous in another. When overexpressed in NB4 neutrophil-like cells and EBV-transformed B cells in vitro, the mutant alleles were found to be LOF, with the exception of the p.R58C and c.120_134del alleles, which were hypomorphic. Particle-induced NADPH oxidase activity was severely impaired in the patients' neutrophils, whereas PMA-induced dihydrorhodamine-1,2,3 (DHR) oxidation, which is widely used as a diagnostic test for chronic granulomatous disease (CGD), was normal or mildly impaired in the patients. Moreover, the NADPH oxidase activity of EBV-transformed B cells was also severely impaired, whereas that of mononuclear phagocytes was normal. Finally, the killing of Candida albicans and Aspergillus fumigatus hyphae by neutrophils was conserved in these patients, unlike in patients with CGD. The patients suffer from hyperinflammation and peripheral infections, but they do not have any of the invasive bacterial or fungal infections seen in CGD. Inherited p40phox deficiency underlies a distinctive condition, resembling a mild, atypical form of CGD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Mutación con Pérdida de Función / Enfermedad Granulomatosa Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Mutación con Pérdida de Función / Enfermedad Granulomatosa Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos